Funding for this research was provided by:
Received: 21 July 2020
Accepted: 13 January 2021
First Online: 22 January 2021
Ethics approval and consent to participate
: The study consisted of a secondary analysis of existing already anonymised data and therefore did not require an ethics approval. All primary observational studies (MAGIC, MAGIC2, MAGYN, MAGYN2) were approved by independent ethical committee and were conducted in accordance with the principles of good clinical practice and the laws of the Russian Federation.
: Not applicable.
: Starostin K., Konchits S., and Bevz A are Sanofi employees. Other authors declare no potential conflict of interest.